ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2021

Abstract Number: 1935

Skewed Escape from X-inactivation: Insights into the Female Bias of Sjögren’s Syndrome

Teressa Shaw1, Wei Zhang2, Sara McCoy3, Xueer Qiu1, Adam Pagenkopf1, Robert Hal Scofield4, Jacques Galipeau3 and Yun Liang1, 1University of Wisconsin-Madison, Madison, WI, 2University of California San Diego, La Jolla, CA, 3University of Wisconsin, Madison, WI, 4Oklahoma Medical Research Foundation, Oklahoma City, OK

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2021

Keywords: autoimmune diseases, Epigenetics, Gene Expression, genomics, Sjögren's syndrome

Session Information

Date: Tuesday, November 9, 2021

Title: Abstracts: Genetics, Genomics & Proteomics (1935–1938)

Session Type: Abstract Session

Session Time: 4:00PM-4:15PM

Background/Purpose: Many autoimmune diseases feature increased prevalence in females, with primary Sjögren’s syndrome (pSS) being the most female-predominant autoimmune disease with a female-to-male ratio of 14:1. Recent evidence suggests that the presence of two X chromosomes may underlie the female bias in pSS. However, the exact X chromosomal alterations on a single-gene level in pSS and their contribution to the female bias in pSS remain elusive. The objective of this study is to define the contribution of X-linked gene expression to pSS pathogenesis, focusing on minor salivary gland-derived mesenchymal stromal cells (MSCs) which are critical players maintaining salivary gland homeostasis.

Methods: Genome-wide, allele-specific expression profiling was performed using MSCs derived from female pSS subjects meeting 2016 ACR/EULAR criteria (n=4) and female control subjects with sicca symptoms but without clinical or laboratory features of autoimmunity (n=4). qRT-PCR of XIST (X-inactive-specific transcript) and quantitative immunostaining of H3K27me3 were performed to assess status of X-chromosome inactivation (XCI) in pSS and control MSCs. Protein localization was analyzed by quantitative immunofluorescence in pSS and control MSCs. Expression levels of IL4 were measured by qRT-PCR before and after MSC adipogenesis to assess the immunomodulatory properties of MSCs. Student’s t-test (two-sample, unequal variances) was used to compare experiment versus control groups for statistical significance.

Results: All pSS MSCs analyzed demonstrated marked skewing of X-linked genes that escape XCI (i.e. escapees), while all control MSCs exhibited balanced escapee expression (Fig. 1). Concomitantly, pSS MSCs showed decrease in XIST expression levels (P < 0.05) and reorganization of heterochromatic, silencing foci in the nucleus (P < 0.05), suggesting a global disruption in XCI maintenance (Fig. 2). The skewing in X-inactivation escape in pSS MSCs was accompanied by mislocalization of protein products encoded by the escapees as well as inflammatory differentiation of MSCs (P < 0.05), consistent with the hallmark features of inflammation and fibrosis in pSS salivary glands (Fig. 3).

Conclusion: We discovered global skewing of X-linked genes in pSS but not control MSCs, and identified escapee skewing as a new mechanism underlying pSS pathogenesis. Given that XCI is a female-specific process, our data suggests that dysregulation of XCI escape contributes to the female bias in pSS.

Figure 1. pSS MSCs demonstrate marked X skewing. Allele-specific transcriptomic profiling of control (N1 – N4) and pSS (SS1 – SS4) female MSCs, showing MAF (minor allele frequency) of heterozygous common SNPs on each chromosome. MAF of ~0.5 suggests equal contribution from maternal and paternal alleles, while MAF < 0.4 suggests skewing. For each sample, MAFs are shown for each chromosome (chromosomes 1_22, X; from left to right), with arrows pointing to MAFs on chromosome X (black for control, red for pSS).

Figure 2. pSS MSCs exhibit XCI defects. A, qRT-PCR of XIST expression levels in control (N) and pSS (SS) MSCs. B, quantification of cells with 0, 1, and 2 H3K27me3+ nuclear foci in control (N) and pSS (SS) MSCs. C, immunofluorescence images of H3K27me3 and DAPI staining of control (N) and pSS (SS) MSCs, with arrows pointing to pSS cells with ectopic H3K27me3+ foci. Mean ± sem, * P < 0.05, two-tailed Student’s t-test.

Figure 3. Escapee skewing in pSS MSCs is accompanied by escapee protein mislocalization and MSC inflammatory differentiation. A, immunostaining of a representative escapee, CHST, in control (N) and pSS (SS) MSCs. Arrow points to CHST+ nuclear foci that are absent in pSS MSCs. B, quantitative nuclear foci analysis in control (N) and pSS (SS) MSCs. C, qRT-PCR of IL4 in undifferentiated (Undiff) and differentiated (Diff) control (N) and pSS (SS) MSCs. Mean ± sem, * P < 0.05, two-tailed Student’s t-test.


Disclosures: T. Shaw, None; W. Zhang, Bristol Myers Squibb, 3, Goldfinch Bio, Inc., 3; S. McCoy, BMS, 2, Novartis, 1, Boehringer Ingelheim, 6; X. Qiu, None; A. Pagenkopf, None; R. Scofield, None; J. Galipeau, CAMBIUM MEDICAL TECHNOLOGIES, 8; Y. Liang, None.

To cite this abstract in AMA style:

Shaw T, Zhang W, McCoy S, Qiu X, Pagenkopf A, Scofield R, Galipeau J, Liang Y. Skewed Escape from X-inactivation: Insights into the Female Bias of Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/skewed-escape-from-x-inactivation-insights-into-the-female-bias-of-sjogrens-syndrome/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/skewed-escape-from-x-inactivation-insights-into-the-female-bias-of-sjogrens-syndrome/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology